bob88体育平台登录

How human challenge trials accelerate vaccine development

Anna Durbin was in Brazil in December 2015 when the Zika virus erupted in the country's northeast. Although she'd flown to São Paulo to work on a dengue vaccine, Durbin returned to Baltimore preoccupied with Zika.

bob电竞

Immunization schedule for children, teens updated for 2023

The American Committee on Immunization Practices (ACIP) Child and Adolescent Immunization Schedule has been updated for 2023 and published as a schedule in the Feb. 10 issue of the U.S. Centers for Disease Control and Prevention ...

Diseases, Conditions, Syndromes

Sudan's tropical disease spike reflects poor health system

The two Sudanese women thought they had malaria and were taking their medication, but things took a dire turn. Both complained of a splitting headache and fever that didn't respond to the anti-malaria treatment.

Diseases, Conditions, Syndromes

Mapping Mexico's dengue fever hotspots

As many as one in five dengue fever deaths in the Americas occur in Mexico, and the rate of the disease's severity has been increasing for decades, according to the World Health Organization. Now, a Rutgers researcher has ...

Vaccination

Japanese dengue vaccine becomes second approved by EU

Japanese pharmaceutical company Takeda said the European Union had given the green light to its dengue fever vaccine, making it the second jab preventing the disease to be approved by the bloc.

Diseases, Conditions, Syndromes

EU regulator recommends clearing Takeda's dengue vaccine

The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.

page2from40